TY - JOUR
T1 - Consistency and reproducibility of next-generation sequencing and other multigene mutational assays
T2 - A worldwide ring trial study on quantitative cytological molecular reference specimens
AU - Malapelle, Umberto
AU - Mayo-de-Las-Casas, Clara
AU - Molina-Vila, Miguel A.
AU - Rosell, Rafael
AU - Savic, Spasenija
AU - Bihl, Michel
AU - Bubendorf, Lukas
AU - Salto-Tellez, Manuel
AU - de Biase, Dario
AU - Tallini, Giovanni
AU - Hwang, David H.
AU - Sholl, Lynette M.
AU - Luthra, Rajyalakshmi
AU - Weynand, Birgit
AU - Vander Borght, Sara
AU - Missiaglia, Edoardo
AU - Bongiovanni, Massimo
AU - Stieber, Daniel
AU - Vielh, Philippe
AU - Schmitt, Fernando
AU - Rappa, Alessandra
AU - Barberis, Massimo
AU - Pepe, Francesco
AU - Pisapia, Pasquale
AU - Serra, Nicola
AU - Vigliar, Elena
AU - Bellevicine, Claudio
AU - Fassan, Matteo
AU - Rugge, Massimo
AU - de Andrea, Carlos E.
AU - Lozano, Maria D.
AU - Basolo, Fulvio
AU - Fontanini, Gabriella
AU - Nikiforov, Yuri E.
AU - Kamel-Reid, Suzanne
AU - da Cunha Santos, Gilda
AU - Nikiforova, Marina N.
AU - Roy-Chowdhuri, Sinchita
AU - Troncone, Giancarlo
AU - the Molecular Cytopathology Meeting Group
N1 - Publisher Copyright:
© 2017 American Cancer Society
PY - 2017/8
Y1 - 2017/8
N2 - BACKGROUND: Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras] oncogene homolog (NRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). Next-generation sequencing (NGS) and other multigene mutational assays are suitable for cytological specimens, including smears. However, the current literature reflects single-institution studies rather than multicenter experiences. METHODS: Quantitative cytological molecular reference slides were produced with cell lines designed to harbor concurrent mutations in the EGFR, KRAS, NRAS, BRAF, and PIK3CA genes at various allelic ratios, including low allele frequencies (AFs; 1%). This interlaboratory ring trial study included 14 institutions across the world that performed multigene mutational assays, from tissue extraction to data analysis, on these reference slides, with each laboratory using its own mutation analysis platform and methodology. RESULTS: All laboratories using NGS (n = 11) successfully detected the study's set of mutations with minimal variations in the means and standard errors of variant fractions at dilution points of 10% (P =.171) and 5% (P =.063) despite the use of different sequencing platforms (Illumina, Ion Torrent/Proton, and Roche). However, when mutations at a low AF of 1% were analyzed, the concordance of the NGS results was low, and this reflected the use of different thresholds for variant calling among the institutions. In contrast, laboratories using matrix-assisted laser desorption/ionization–time of flight (n = 2) showed lower concordance in terms of mutation detection and mutant AF quantification. CONCLUSIONS: Quantitative molecular reference slides are a useful tool for monitoring the performance of different multigene mutational assays, and this could lead to better standardization of molecular cytopathology procedures. Cancer Cytopathol 2017;125:615-26.
AB - BACKGROUND: Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor receptor (EGFR), emerging predictive/prognostic genomic biomarkers such as Kirsten rat sarcoma viral oncogene homolog (KRAS), neuroblastoma RAS viral [v-ras] oncogene homolog (NRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA). Next-generation sequencing (NGS) and other multigene mutational assays are suitable for cytological specimens, including smears. However, the current literature reflects single-institution studies rather than multicenter experiences. METHODS: Quantitative cytological molecular reference slides were produced with cell lines designed to harbor concurrent mutations in the EGFR, KRAS, NRAS, BRAF, and PIK3CA genes at various allelic ratios, including low allele frequencies (AFs; 1%). This interlaboratory ring trial study included 14 institutions across the world that performed multigene mutational assays, from tissue extraction to data analysis, on these reference slides, with each laboratory using its own mutation analysis platform and methodology. RESULTS: All laboratories using NGS (n = 11) successfully detected the study's set of mutations with minimal variations in the means and standard errors of variant fractions at dilution points of 10% (P =.171) and 5% (P =.063) despite the use of different sequencing platforms (Illumina, Ion Torrent/Proton, and Roche). However, when mutations at a low AF of 1% were analyzed, the concordance of the NGS results was low, and this reflected the use of different thresholds for variant calling among the institutions. In contrast, laboratories using matrix-assisted laser desorption/ionization–time of flight (n = 2) showed lower concordance in terms of mutation detection and mutant AF quantification. CONCLUSIONS: Quantitative molecular reference slides are a useful tool for monitoring the performance of different multigene mutational assays, and this could lead to better standardization of molecular cytopathology procedures. Cancer Cytopathol 2017;125:615-26.
KW - cytological molecular reference
KW - cytology
KW - lung cancer
KW - molecular cytopathology
KW - multigene mutational assay
KW - next-generation sequencing
UR - http://www.scopus.com/inward/record.url?scp=85018382453&partnerID=8YFLogxK
U2 - 10.1002/cncy.21868
DO - 10.1002/cncy.21868
M3 - Article
C2 - 28475299
AN - SCOPUS:85018382453
SN - 1934-662X
VL - 125
SP - 615
EP - 626
JO - Cancer cytopathology
JF - Cancer cytopathology
IS - 8
ER -